Ivonne Rietjens

Ivonne Rietjens


Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2016 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
IRIvonne Rietjens
Ivonne Rietjens
JLJochem Louisse
Jochem Louisse
KBKarsten Beekmann
Karsten Beekmann
Phytoestrogens are plant‐derived dietary compounds with structural similarity to 17‐β‐oestradiol (E2), the primary female sex hormone. This structural similarity to E2 enables phytoestrogens to cause (anti)oestrogenic effects by binding to the oestrogen receptors. The aim of the present review is to present a state‐of‐the‐art overview of the potential health effects of dietary phytoestrogens. Various beneficial health effects have been ascribed to phytoestrogens, such as a lowered risk of menopausal symptoms like hot flushes and osteoporosis, lowered risks of cardiovascular disease, obesity, metabolic syndrome and type 2 diabetes, brain function disorders, breast cancer, prostate cancer, bowel cancer and other cancers. In contrast to these beneficial health claims, the (anti)oestrogenic properties of phytoestrogens have also raised concerns since they might act as endocrine disruptors, indicating a potential to cause adverse health effects. The literature overview presented in this paper illustrates that several potential health benefits of phytoestrogens have been reported but that, given the data on potential adverse health effects, the current evidence on these beneficial health effects is not so obvious that they clearly outweigh the possible health risks. Furthermore, the data currently available are not sufficient to support a more refined (semi) quantitative risk–benefit analysis. This implies that a definite conclusion on possible beneficial health effects of phytoestrogens cannot be made.Linked Articles: This article is part of a themed section on Principles of Pharmacological Research of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.11/issuetoc

1 July 2005 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
VBVincent C.J. de Boer
Vincent C.J. de Boer
ADAshwin A. Dihal
Ashwin A. Dihal
HWHester van der Woude
Hester van der Woude
IAIlja C. W. Arts
Ilja C. W. Arts
SWSiegfried Wolffram
Siegfried Wolffram
PHPeter C. H. Hollman
Peter C. H. Hollman
Quercetin is a dietary polyphenolic compound with potentially beneficial effects on health. Claims that quercetin has biological effects are based mainly on in vitro studies with quercetin aglycone. However, quercetin is rapidly metabolized, and we have little knowledge of its availability to tissues. To assess the long-term tissue distribution of quercetin, 2 groups of rats were given a 0.1 or 1% quercetin diet [∼50 or 500 mg/kg body weight (wt)] for 11 wk. In addition, a 3-d study was done with pigs fed a diet containing 500 mg quercetin/kg body wt. Tissue concentrations of quercetin and quercetin metabolites were analyzed with an optimized extraction method. Quercetin and quercetin metabolites were widely distributed in rat tissues, with the highest concentrations in lungs (3.98 and 15.3 nmol/g tissue for the 0.1 and 1% quercetin diet, respectively) and the lowest in brain, white fat, and spleen. In the short-term pig study, liver (5.87 nmol/g tissue) and kidney (2.51 nmol/g tissue) contained high concentrations of quercetin and quercetin metabolites, whereas brain, heart, and spleen had low concentrations. These studies have for the first time identified target tissues of quercetin, which may help to understand its mechanisms of action in vivo.

1 October 2001 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
KPKatarzyna Pawlak-Lemańska
Katarzyna Pawlak-Lemańska
HSHenryk Szymusiak
Henryk Szymusiak
BTBożena Tyrakowska
Bożena Tyrakowska
RZRyszard Zieliński
Ryszard Zieliński
ASAns E.M.F Soffers
Ans E.M.F Soffers
IRIvonne Rietjens
Ivonne Rietjens

1 July 2002 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
IRIvonne Rietjens
Ivonne Rietjens
MBMarelle G. Boersma
Marelle G. Boersma
LHLaura de Haan
Laura de Haan
BSBert Spenkelink
Bert Spenkelink
HAHanem Awad
Hanem Awad
JKJan H. Koeman
Jan H. Koeman

1 September 2001 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
NCNicole H.P Cnubben
Nicole H.P Cnubben
IRIvonne Rietjens
Ivonne Rietjens
HWHeleen Wortelboer
Heleen Wortelboer
JZJelmer van Zanden
Jelmer van Zanden
PBPeter J van Bladeren
Peter J van Bladeren

11 September 2010 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
SBSourav Bhattacharjee
Sourav Bhattacharjee
LHLaura Hj de Haan
Laura Hj de Haan
NENynke M Evers
Nynke M Evers
XJXue Jiang
Xue Jiang
AMAntonius Tm Marcelis
Antonius Tm Marcelis
GAGerrit M Alink
Gerrit M Alink
Background: Surface charge and oxidative stress are often hypothesized to be important factors in cytotoxicity of nanoparticles. However, the role of these factors is not well understood. Hence, the aim of this study was to systematically investigate the role of surface charge, oxidative stress and possible involvement of mitochondria in the production of intracellular reactive oxygen species (ROS) upon exposure of rat macrophage NR8383 cells to silicon nanoparticles. For this aim highly monodisperse (size 1.6 ± 0.2 nm) and well-characterized Si core nanoparticles (Si NP) were used with a surface charge that depends on the specific covalently bound organic monolayers: positively charged Si NP-NH2, neutral Si NP-N3 and negatively charged Si NP-COOH. Results: Positively charged Si NP-NH2 proved to be more cytotoxic in terms of reducing mitochondrial metabolic activity and effects on phagocytosis than neutral Si NP-N3, while negatively charged Si NP-COOH showed very little or no cytotoxicity. Si NP-NH2 produced the highest level of intracellular ROS, followed by Si NP-N3 and Si NP-COOH; the latter did not induce any intracellular ROS production. A similar trend in ROS production was observed in incubations with an isolated mitochondrial fraction from rat liver tissue in the presence of Si NP. Finally, vitamin E and vitamin C induced protection against the cytotoxicity of the Si NP-NH2 and Si NP-N3, corroborating the role of oxidative stress in the mechanism underlying the cytotoxicity of these Si NP. Conclusion: Surface charge of Si-core nanoparticles plays an important role in determining their cytotoxicity. Production of intracellular ROS, with probable involvement of mitochondria, is an important mechanism for this cytotoxicity.